Copyright
©The Author(s) 2018.
World J Gastroenterol. Nov 7, 2018; 24(41): 4691-4697
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4691
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4691
Table 2 In-hospital complications after endoscopic retrograde cholangiopancreatography from 2011 to 2013 based on data from the Nationwide Inpatient Sample comparing end-stage renal disease to controls n (%)
| Type of complications | ESRDn = 7347 | Controln = 445424 | CrudeOR/MD (95%CI) | AdjustedOR/MD (95%CI) | AdjustedP value |
| Death | 526 (7.1) | 5138 (1.15) | 6.6 (5.3-8.2) | 3.7 (2.9–4.6) | < 0.001 |
| Pancreatitis | 611 (8.3) | 20315 (4.6) | 1.9 (1.6-2.3) | 1.7 (1.4-2.1) | < 0.001 |
| Bleeding | 377 (5.1) | 6546 (1.5) | 3.6 (2.86-4.59) | 1.86 (1.4-2.4) | < 0.001 |
| Perforation | 14 (0.2) | 340 (0.07) | 2.6 (0.8–8.4) | 3 (0.86–10.00) | 0.08 |
| Length of hospital stay, mean days (SE) | 13 (0.46) | 6 (0.03) | 7.2 (6.4-8.0) | 5.9 (5.0-6.7) | < 0.001 |
- Citation: Sawas T, Bazerbachi F, Haffar S, Cho WK, Levy MJ, Martin JA, Petersen BT, Topazian MD, Chandrasekhara V, Abu Dayyeh BK. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24(41): 4691-4697
- URL: https://www.wjgnet.com/1007-9327/full/v24/i41/4691.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i41.4691